Faegre Drinker Biddle & Reath LLP, a Delaware limited liability partnership | This website contains attorney advertising.

Biosciences & Public Health

Overview

From manufactures and pharmacies to the patients who benefit from the delivery of care, Faegre Drinker's biosciences and public health team partners with clients to develop and deliver medicine, treatment, and patient access to care across the public health spectrum. Our highly experienced and interdisciplinary team of attorneys, medical doctors, PhDs, and senior public health leaders combines 50+ years of legal, government relations, science, and research experience to develop and implement policy solutions that support patient access to care. Our clients include nonprofit organizations, patient communities, patient-focused drug development companies, patient advocacy organizations, pharmaceutical companies and manufactures, pharmacies, digital health technology, and telehealth companies.

Faegre Drinker Consulting professionals do not act as attorneys for clients. Learn more about the Faegre Drinker Consulting practice.

Insights & Events

Insights
Updates February 2026

FDA Publishes Long-Awaited Draft Guidance on “Plausible Mechanism Framework” to Spur the Development of New Individualized Medicines

Anticipated Deadline for Comments Is April 27, 2026
7 min read
Updates November 2025

What Does the Agreement to Reopen the Federal Government Mean for Health Policy Interests?

And What Opportunities May Lie Ahead?
5 min read
Media Mentions October 2025

Libby Baney Comments on Uncertainty in Prescription Drug Market With the Washington Post

1 min read
Published Articles October 2025

'Most-Favored Nation' Drug Pricing: Impacts on the Pharmacy Supply Chain

National Association of Boards of Pharmacy’s Innovations
1 min read
Media Mentions September 2025

Megan Herber Discusses Health Care Price Transparency Policy With Oncology Practices

Oncology News Central
1 min read
Media Mentions May 2025

Nisha Quasba Comments on Drug Importation From Canada in Law360

1 min read
Media Mentions May 2025

Nisha Quasba Discusses Trump’s Push to Boost Drug Imports in Bloomberg Law

1 min read
Published Articles April 2025

Accuracy of Medicare Information Provided by State Health Insurance Assistance Programs

1 min read
Published Articles March 2025

Breaking the Silence: Challenges and Opportunities in Pediatric Drug Development

1 min read
Updates February 2025

A Deeper Dive Into the Making America Healthy Again Commission’s Executive Order and Its Implications

While Some Elements Lie Within the Mainstream, Others Are Cause for Concern
5 min read